Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Genghua Xu"'
Autor:
Zhanxun Wu, Wenping Yan, Ke Wang, Genghua Xu, Danyan Zhu, Xuyun Li, Huafeng Wang, Min Yang, Xiangnan Zhang, Jiaying Wu
Publikováno v:
Archives of Toxicology. 97:1385-1396
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca021773eb51d78cae081cac45e14201
https://doi.org/10.1007/s00204-023-03468-6
https://doi.org/10.1007/s00204-023-03468-6
Autor:
Zhanxun Wu, Wenping Yan, Ke Wang, Genghua Xu, Danyan Zhu, Xuyun Li, Huafeng Wang, Min Yang, Xiangnan Zhang, Jiaying Wu
Bortezomib (BTZ) is a proteasome inhibitor serves as a first-line drug for multiple myeloma treatment. BTZ-induced peripheral neuropathy (BIPN) is the most common adverse effect of BTZ with an incidence as high as 40%-60%. However, the pathological m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a029d6d0437ff9a961adcb9e7dbe1f4
https://doi.org/10.21203/rs.3.rs-2241499/v1
https://doi.org/10.21203/rs.3.rs-2241499/v1
